Abstract-Hypertension occurs with higher prevalence and morbidity in black Americans compared with other groups.
N early 45% of black Americans have high blood pressure (BP). 1 The prevalence of hypertension and the severity of cardiovascular morbidity are greater for blacks than other racial groups, but the reasons for these differences are not well understood. 2 The influence of the sympathetic nervous system on BP is mediated predominantly through catecholamines (epinephrine and norepinephrine) binding to adrenergic receptors. ␤-Adrenergic receptors (␤ARs) are critical for regulating peripheral resistance, and disruption in their signaling can lead to an attenuation of vasodilation and subsequent BP elevation. 3, 4 Although the pathophysiology of high BP is undeniably complex, increased vascular resistance, 5, 6 ␤AR derangement, 5, 7, 8 and increased plasma norepinephrine 3, 9 are likely involved. In addition, norepinephrine levels increase early in the progression of hypertension 10 and are inversely correlated with lymphocyte ␤AR density, 11 suggesting that understanding the impact of neurohormonal activation is important to understanding the development and progression of hypertension.
Constant stimulation of ␤ARs by catecholamines in heart failure and hypertension leads to selective ␤AR downregulation and an overall attenuation of ␤AR-mediated adenylyl cyclase activity. [12] [13] [14] G protein-coupled receptor kinases (GRKs) are important serine/threonine kinase regulators of agonist-occupied 7 transmembrane-spanning receptors (7TMRs), including ␤ARs. 15 GRK2 and GRK5 are the most abundant GRKs in the cardiovascular system. In hypertensive rat models, an increase in lymphocyte GRK2 expression was reflected by a parallel increase in vascular smooth muscle (VSM) GRK2 expression. 16 In humans, it was found that lymphocyte GRK2 expression directly correlated with GRK2 in biopsies from the right atria of the same patient. 17 It has been suggested that human lymphocyte GRK2 expression and activity are increased, at least in a small cohort of young white subjects with borderline hypertension. 18 Experimentally, we have shown in transgenic mouse models that increasing the expression of GRK2 in VSM was sufficient to increase BP. 19 Our data suggested that attenuation in vasodilation, mediated by ␤ARs, is an important contributor to the high BP in these mice. 19 Alterations in adrenergic nervous system activity appear to play a role in development and maintenance of high BP, 20 and racial variations in the interplay of adrenergic activity and BP have been described. 21, 22 The role of ␤ARs and their desensitization is not well delineated in humans, especially in blacks. The purpose of this study was to quantify lymphocyte GRK2 activity in a human sample of black Americans and to determine whether there is an association of GRK2 levels with plasma catecholamines and BP. An increase in GRK2 levels may indicate increased neurohormonal activity and give insight into the pathogenesis of high BP.
Methods

Study Sample
Data were obtained from predominantly black participants who were enrolled in an ongoing cohort study on biomarkers of hypertension and cardiovascular injury. BP measurements were obtained according to well-standardized procedures 23 and fully described in the online supplementary Methods (please see http://hyper.ahajournals. org). On the basis of the average systolic and diastolic BPs, participants were stratified as having normal BP (average BP: Ͻ130/80 mm Hg) or high BP (systolic BP: Ն130 mm Hg and/or diastolic BP: Ն85 mm Hg). The Adult Treatment Panel III criteria for high BP 24 were used to designate high BP in the cohort study because other parameters of metabolic syndrome were under investigation. Individuals who were taking antihypertensive medication for BP control were designated as having high BP regardless of the BP level. Fasting blood samples were collected into 8-mL Vacutainer CPT Collection Preparation Tubes with sodium citrate (Becton Dickinson), which facilitated the selection of lymphocytes. Lymphocytes and plasma were isolated and stored at Ϫ80°C.
RNA Isolation and cDNA Construction and Quantitative RT-PCR
RNA was isolated and cDNA constructed using standard procedures, as fully described (see the online Supplemental Methods). Real-time PCR was performed in duplicate using primers as described in Table S1 , and product verification was confirmed with a 9-point standard curve, sequencing, melting point curve analysis, and agarose gel electrophoresis, as fully described in the online supplemental Methods.
Immunoblot Analysis
Immunoblotting was performed in 35 g of lymphocyte protein using a GRK2 primary antibody (C15, Santa Cruz Biotechnology), as fully described in the online supplemental Methods.
GRK Activity
GRK enzymatic activity was assessed via determination of the extent of light-dependent phosphorylation of rhodopsin according to methods published previously. 25 Sample phosphorylation results were normalized on a 7-point standard curve of rhodopsin phosphorylation performed with purified GRK2 (0.03 to 2000.00 ng, Invitrogen).
Measurement of Plasma Catecholamine Levels
Plasma epinephrine and norepinephrine levels were assessed according to the manufacturer's protocol (Human Bi-CAT enzyme immunoassay, Alpco Diagnostics) from plasma extracted from the same sample as lymphocyte extraction. Conditions for obtaining the blood samples were uniform in all of the participants, including overnight fasts, absence of nicotine or caffeine exposure, and 45 minutes of rest. 23 Samples with significant hemolysis and lipolysis were excluded, as were those that fell outside the linear portion of the standard curve.
Statistical Analysis
The relative quantifications of RT-PCR results were performed by using the mathematical model with 2
Ϫ⌬⌬Ct method, 26 as well as by being compared with standard amounts of GRK2 and GRK5. GRK2 and GRK5 mRNA expressions were calculated and normalized to the levels of 28S mRNA. As described above, subjects were stratified into 2 BP groups (normal BP: systolic BP Ͻ130 mm Hg and diastolic BP Ͻ85 mm Hg; high BP: systolic BP Ն130 mm Hg and/or diastolic BP Ն85 mm Hg). Participants who were taking antihypertensive medications were designated as having high BP. According to these criteria, there were no individuals who had isolated diastolic hypertension. Therefore, the statistical analyses focused on systolic BP as a continuous and categorical variable. The most parsimonious multivariable models of GRK2 and GRK5 were used to better understand their clinical implications in relation to high BP, diabetes mellitus, obesity, and sex. Analyses were completed via the appropriate contrasts from the mixed-effects linear regression model, allowing for variance differences among the groups. Contrasts were computed and tested using the appropriate estimates of effects and SEs as computed from the variance-covariance matrix of parameter estimates. When distributions were not appropriately symmetrical, even with transformation, then nonparametric regression methods were completed using, eg, median regression. We then completed bivariate and multivariate analyses of all of the parameters. Data are expressed as meanϮSEM. Data were analyzed using 1-way ANOVA, 2-way ANOVA, or unpaired 2-tailed Student t test, as indicated.
Results
Study Sample Population
The study sample included 133 subjects, ages 18 to 67 years (Tables S2 and S3 ). In this cohort, systolic BP ranged from 90 to 188 mm Hg. Using a cut point of 130 mm Hg as a threshold (systolic BP: Ն130 mm Hg), 71% of the sample was below this threshold, and 29% of the sample had a systolic BP Ն130 mm Hg. The distribution of men (47.5%) and women (52.5%) was equivalent; 132 subjects were black.
GRK2 mRNA and Systolic BP
Robustness of the quantitative real-time PCR analysis was verified ( Figure S1 ). Lymphocytes from the first 99 samples were used to determine GRK2 and GRK5 mRNA expressions (Table S2 ). Figure 1 provides data on the relationship of mRNA expression with systolic BP. There is a statistically significant correlation of GRK2 mRNA expression with systolic BP ( Figure 1A ), and GRK2 mRNA expression was significantly higher in the group of subjects with a systolic BP Ն130 mm Hg as compared with Ͻ130 mm Hg ( Figure  1B ). The increase in GRK2 mRNA expression was even more profound in men with systolic BP Ն130 mm Hg ( Figure 1C ). There was no significant correlation between GRK5 mRNA expression and systolic BP level for the total sample ( Figure  1D ) or when the data were analyzed for men and women separately (data not shown).
Univariate analysis was performed for GRK2 and GRK5 mRNA levels with age, sex, systolic BP, body mass index, diabetic status, and hypertensive treatment (Table) . Only systolic BP correlated significantly with GRK2 mRNA levels (Pϭ0.004). There was no correlation between GRK5 mRNA and systolic BP in univariate analysis.
Multivariate analysis was performed with GRK2 mRNA as the dependent variable with systolic BP, sex, body mass index, diabetic status, and antihypertensive treatment status as independent variables (Table) . In this model, systolic BP is the major determinant of GRK2 mRNA expression, with some small additional contribution of sex and body mass index.
We also considered GRK2 mRNA expression as compared with diastolic BP using 80 mm Hg to group the population, because this is considered the cutoff value for normal diastolic BP. GRK2 mRNA was increased if diastolic BP was Ն80 mm Hg (Pϭ0.0082; Figure S2 ).
GRK2 Protein and Systolic BP
In the next 10 subjects who were recruited, protein expression was determined by immunoblot analysis. There was a significant correlation of GRK2 protein expression with systolic BP, and GRK2 protein was higher in those with systolic BP Ն130 mm Hg compared with those with systolic BP Ͻ130 mm Hg (Figure 2 ).
GRK Activity and Systolic BP
GRK activity in the human lymphocyte extracts was measured using a rhodopsin phosphorylation assay in the next 24 subjects. All of the GRKs are able to phosphorylate rhodopsin; however, GRK2 and GRK5 are the most abundant GRKs in the lymphocyte (data not shown). Rhodopsin phosphorylation assay determines total GRK activity in a sample, and, therefore, we refer to this as "GRK activity." Autoradiography of a 7-point standard curve produced with increasing doses of purified GRK2 and rhodopsin substrate in the presence of radiolabeled ATP demonstrates assay sensitivity ( Figure 3) . Verification of assay robustness is shown in Figure S3 . GRK activity was increased in subjects with systolic BP Ն130 mm Hg compared with those with systolic BP Ͻ130 mm Hg (Figure 3) . We did not detect GRK5 mRNA changes and, therefore, predict that the activity changes that we observed are because of GRK2 activity attributed to increased mRNA ( Figure 1 ) and protein expression (Figure 2 ), although this remains to be fully determined.
Plasma Norepinephrine Levels Directly Correlate With Systolic BP
In our sample of black adults, there was a small but statistically significant correlation of plasma norepinephrine level with systolic BP ( Figure 4A) . No relationship of plasma epinephrine level with BP was detected ( Figure 4B) . A direct correlation was detected for plasma norepinephrine levels with GRK2 mRNA ( Figure 4C) .
Discussion
In the current study, we found that GRK2 but not GRK5 mRNA, protein, and activity directly correlated with systolic BP and plasma norepinephrine levels in black adults, a population at higher risk for hypertension and cardiovascular complications. An increase in 7TMR signaling leads to an increase in GRKs. 15 Sympathetic nerves of the heart, kidneys, and skeletal muscle vasculature in hypertensive patients are activated, and sympathetic overactivity in the renal sympathetic outflow is a prominent pathophysiological feature in hypertensive patients. [27] [28] [29] Greater sympathetic nervous system activation in black American adults has been reported, 29 and our data confirm an increase in plasma norepinephrine levels with increased systolic BP. An increase in sympathetic nervous system activity results in an increase in ␤AR signaling and subsequent GRK-mediated ␤AR desensitization. In our black subjects, we found that, as BP and norepinephrine levels increased, there was a corresponding increase in lymphocyte GRK2 but not GRK5 expression and activity. The increased norepinephrine and GRK2 that we observed may contribute to a decrease in ␤AR signaling. Hypertensive black Americans also tend to be at higher risk for increased circulating plasma endothelin levels, 30 and endothelin receptors are preferentially desensitized by GRK2. 31 Hypertension has been associated with increased plasma levels of other ligands, including the components of the renin-angiotensin system, 32 although hypertension in black Americans tends to be low renin in nature. 30 Like endothelin receptors, angiotensin II type 1 receptors are regulated by GRK2. Thus, the increase in GRK2 that we observed may be attributable not only to increased plasma norepinephrine but also to increases in plasma or local levels of endothelin, angiotensin II, and/or perhaps other endogenous ligands. Although no change in GRK5 mRNA expression was observed, we did not investigate whether the Q41L polymorphism exists, a nonsynonymous polymorphism of GRK5 that is associated with a cardioprotection phenotype in black Americans. 33 Data are accumulating to provide support for a direct relationship between GRKs and BP. We found previously that VSM overexpression of either GRK2 or GRK5 alone was sufficient to increase basal BP in mice. 19, 34 Increased GRK2 is associated with increased BP in both lymphocytes and VSM cells of 2 different high-BP rat models, the spontaneously hypertensive rat and the Dahl salt-sensitive hypertensive rat. 16 In addition to the animal studies, in a small cohort of young white hypertensive subjects (nϭ8), lymphocyte GRK2 protein and activity levels were increased compared with normotensive, age-matched control subjects. 35 GRK5 is increased in rat VSMs during both angiotensin II and norepinephrine-induced hypertension. 36 The augmented GRK5 level was attenuated by concurrent hydralazine administration, suggesting that hemodynamic stress itself was responsible for the GRK5 increase. 36 Data from our laboratory suggest that the role of GRK in BP regulation is variable. In previous studies, we found that mice with increased VSM cell GRK2 expression have high BP and also have both VSM and cardiac hypertrophy. In contrast, mice with increased expression of VSM cell GRK5 have high BP without concomitant hypertrophy. Whether increased expression of GRK2 is also a predictor of increased cardiovascular risk and propensity toward increased morbidity remains to be determined.
In the current study, there was a direct correlation of GRK2, but not GRK5, with BP. Although the correlation in this study is low, our sample population was mostly considered to have BP within "normal" limits or to be "prehypertensive." It will be particularly important to further test the direct correlation between GRK2 and BP in a greater number of subjects with high BP. GRK2 upregulation occurs with heart failure. 37 The increase in GRK2 in heart failure acts to decrease ␤AR signaling, leading to ionotropic and chronotropic decreases. It would seem counterintuitive, at least from a cardiac perspective, that increased GRK2 is associated with an increase in BP. However, the cardiovascular system is a highly complex system with multiple inputs and sites of regulation, including the heart, vasculature, brain, and kidney, as well as a multitude of different receptors and signaling pathways. Previously, we found that an increase in cardiac GRK2 accompanies an increase in BP that precedes cardiac dysfunction in the spontaneously hypertensive heart failure rat model. 38 We predict, and data in this article suggest, that GRK2 levels are at least somewhat reflective of catecholamine activity. It remains to be determined how signaling by other hormones and neurotransmitters affects GRK2 levels, but it could be that, depending on the etiology of the high BP, the ligand that results in an increase in GRK2 might have minimal cardiac effects.
Perspectives
In American blacks, we have found that norepinephrine levels correlate with systolic BP. In addition, both norepinephrine and systolic BP directly correlate with GRK2 expression and activity. GRK2 is upregulated with stimulation of specific 7TMRs, including ␤ARs, and its increase can have a profound impact on 7TMR signaling and, therefore, BP control. Understanding GRK levels may give us insight into the 7TMRs stimulated during hypertension, thus potentially broadening our understanding of etiology and progression of the disease, and may contribute to improved therapies and more targeted treatment strategies to control hypertension and reduce cardiovascular morbidity in this at-risk population. 
GRK Activity 24
Total 133 Subject samples were studied by one of three methods as described in Materials and Methods and processed for GRK mRNA, protein or activity in order of recruitment. Figure S1A ). Exclusion criteria for patient RNA samples included RNA 260:280 absorbance ratio above 1.8 determined by NanoDrop ND-1000 (Wilmington, DE) and RNA visualization. Specific SYBR Green amplification of our two target genes (GRK2 and GRK5) and housekeeping gene (28S) were confirmed. GRK2 and GRK5 standard curves were created using RNA constructed from bovine GRK2 and human GRK5 sequences. Linearity of the standard curves is seen at the exponential phase of PCR and optimal threshold positions were restricted to lower half of the fluorescence plots in the exponential phase ( Figure S1B ). Figure S1C illustrates Ct threshold values of both our standards and patient samples, which fall neatly within our standards. A, Gel electrophoresis of RNA extraction from subjects #21-29. One microgram loading of samples demonstrated clear 28S and 18S bands of rRNA. Stringent exclusion criteria for patient RNA samples; RNA 260:280 absorbance ratio above 1.8 determined by NanoDrop ND-1000 (Wilmington, DE) and RNA quality (intactness) determine by on an Agilent 2100 Bioanalyzer (Foster City, CA). B, Linearity of the standard curves is seen at the exponential phase of PCR and optimal threshold positions were restricted to lower half of the fluorescence plots in the exponential phase. C, PCR amplification and Ct threshold graph representation of both our standards and patient samples; patient samples (light and dark purple) fall neatly within the standard curve. 
